Staff turmoil continues at Focus Surgery, the Milpitas, CA, developerof high-frequency ultrasound ablation products. The firm announcedlate last month that CFO John Kehoe has stepped down. His dutieswill be assumed temporarily by vice president of
Staff turmoil continues at Focus Surgery, the Milpitas, CA, developerof high-frequency ultrasound ablation products. The firm announcedlate last month that CFO John Kehoe has stepped down. His dutieswill be assumed temporarily by vice president of planning PaulSullivan.
Kehoe's departure came several weeks after Focus cut its workforce by 40% (SCAN 9/27/95). Focus has posted a string of losingquarters as it moves to commercialize its Sonablate 200 productfor treatment of benign prostatic hyperplasia. The company saidlast month that it "continues to examine all financing alternatives,"but declined to be more specific about what those alternativesmight be.
New MRI Research Explores Links Between Waist-to-Hip Ratio and Memory in Aging
March 13th 2025Researchers found that a higher waist-to-hip ratio in midlife was associated with higher mean diffusivity in 26 percent of total white matter tracts in the cingulum as well as the superior and inferior longitudinal fasciculus.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.